UroGen Pharma Ltd. (URGN)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
- Fiscal year ends Dec 31
In fiscal 2025, UroGen Pharma Ltd. reported revenue of $109.79M, up 21.4% from the prior year. The company ran a net loss, with a net margin of -139.8% and a gross margin of 88.7%. It held $200.46M in total assets against $305.93M in total liabilities.
Key ratios (FY2025)
88.7%
Gross margin
-113.7%
Operating margin
-139.8%
Net margin
+21.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.79M | $90.40M | $82.71M | $64.36M | $48.04M | $11.80M | $18.0K | $1.13M | $8.16M | — |
| Cost of Revenue | $12.45M | $8.88M | $9.36M | $7.65M | $5.16M | $1.01M | — | $1.80M | $600.0K | $28.0K |
| Gross Profit | $97.34M | $81.52M | $73.35M | $56.70M | $42.88M | $10.79M | $18.0K | -$675.0K | $7.56M | $17.50M |
| Operating Income | -$124.86M | -$96.78M | -$65.54M | -$79.04M | -$92.29M | -$126.74M | -$109.48M | -$77.18M | -$19.95M | $798.0K |
| Net Income | -$153.49M | -$126.87M | -$102.24M | -$109.78M | -$110.82M | -$128.48M | -$105.15M | -$75.66M | -$20.00M | -$1.94M |
| EPS (Diluted) | $-3.19 | $-2.96 | $-3.55 | $-4.81 | $-4.96 | — | — | — | — | — |
| Total Assets | $200.46M | $285.71M | $178.31M | $135.62M | $119.75M | $122.00M | $202.39M | $103.56M | $75.55M | $23.06M |
| Total Liabilities | $305.93M | $294.51M | $243.52M | $224.98M | $111.33M | $25.65M | $22.09M | $13.46M | $7.04M | $6.75M |
| Shareholders' Equity | -$105.47M | -$8.80M | -$65.21M | -$89.36M | $8.41M | $96.36M | $180.30M | $90.09M | $68.52M | $16.31M |
| Cash & Equivalents | $110.75M | $171.99M | $95.00M | $55.41M | $44.36M | $52.86M | $49.69M | $101.32M | $37.00M | $21.36M |
| Operating Cash Flow | -$162.44M | -$96.77M | -$76.38M | -$87.56M | -$84.89M | -$105.89M | -$71.02M | -$37.33M | -$9.57M | $4.19M |
| Capital Expenditures | $289.0K | $295.0K | $194.0K | $254.0K | $752.0K | $1.22M | $325.0K | $560.0K | $271.0K | $695.0K |
| Shares Outstanding | 48.35M | 42.23M | 32.49M | 23.13M | 22.46M | 22.17M | 21.03M | 16.21M | 13.75M | 2.31M |